Brief: Can-Fite signs distribution deal for liver cancer drug CF102 in South Korea

Chong Kun Dang Pharmaceutical

25/10/2016 12:15

Oct 25 (Reuters) - Chong Kun Dang Pharmaceutical Corp : 
    * Can-Fite signs distribution deal for liver cancer drug 
CF102 in South Korea 
    * Can fite biopharma says signed a distribution agreement 
with Chong Kun Dang Pharmaceuticals for exclusive right to 
distribute CF102 
    * Deal provides for up to $3 million in upfront and 
milestone payments & a percentage rate of royalty payments in 
low twenties 
 
Source text for Eikon:  ID:nPn1GhNhla  
Further company coverage:  185750.KS  
 
 ((Bangalore.newsroom@thomsonreuters.com;))